240 related articles for article (PubMed ID: 22549295)
1. A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods.
Ritter P; Delnoy PP; Padeletti L; Lunati M; Naegele H; Borri-Brunetto A; Silvestre J
Europace; 2012 Sep; 14(9):1324-33. PubMed ID: 22549295
[TBL] [Abstract][Full Text] [Related]
2. Implantation feasibility, procedure-related adverse events and lead performance during 1-year follow-up in patients undergoing triple-site cardiac resynchronization therapy: a substudy of TRUST CRT randomized trial.
Lenarczyk R; Kowalski O; Sredniawa B; Pruszkowska-Skrzep P; Mazurek M; Jędrzejczyk-Patej E; Woźniak A; Pluta S; Głowacki J; Kalarus Z
J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1228-36. PubMed ID: 22651239
[TBL] [Abstract][Full Text] [Related]
3. Whether noninvasive optimization of AV and VV delays improves the response to cardiac resynchronization therapy.
Urbanek B; Chudzik M; Klimczak A; Rosiak M; Lewek J; Wranicz JK
Cardiol J; 2013; 20(4):411-7. PubMed ID: 23913460
[TBL] [Abstract][Full Text] [Related]
4. Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
De Marco T; Wolfel E; Feldman AM; Lowes B; Higginbotham MB; Ghali JK; Wagoner L; Kirlin PC; Kennett JD; Goel S; Saxon LA; Boehmer JP; Mann D; Galle E; Ecklund F; Yong P; Bristow MR
J Card Fail; 2008 Feb; 14(1):9-18. PubMed ID: 18226768
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial comparing simultaneous versus optimized sequential interventricular stimulation during cardiac resynchronization therapy.
Abraham WT; León AR; St John Sutton MG; Keteyian SJ; Fieberg AM; Chinchoy E; Haas G
Am Heart J; 2012 Nov; 164(5):735-41. PubMed ID: 23137504
[TBL] [Abstract][Full Text] [Related]
6. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
Hsu JC; Solomon SD; Bourgoun M; McNitt S; Goldenberg I; Klein H; Moss AJ; Foster E;
J Am Coll Cardiol; 2012 Jun; 59(25):2366-73. PubMed ID: 22698490
[TBL] [Abstract][Full Text] [Related]
7. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
[TBL] [Abstract][Full Text] [Related]
8. Cardiac resynchronization therapy in patients undergoing atrioventricular junction ablation for permanent atrial fibrillation: a randomized trial.
Brignole M; Botto G; Mont L; Iacopino S; De Marchi G; Oddone D; Luzi M; Tolosana JM; Navazio A; Menozzi C
Eur Heart J; 2011 Oct; 32(19):2420-9. PubMed ID: 21606084
[TBL] [Abstract][Full Text] [Related]
9. Feasibility, safety, and mid-term efficacy of cardiac resynchronization therapy in patients with severe heart failure and ventricular conduction delay: Chulalongkorn experience.
Sunsaneewitayakul B; Sitthisook S; Sangwatanaroj S; Prechawat S; Songmuang SB
J Med Assoc Thai; 2007 Jul; 90(7):1458-66. PubMed ID: 17710992
[TBL] [Abstract][Full Text] [Related]
10. Long-term effects of upgrading from right ventricular pacing to cardiac resynchronization therapy in patients with heart failure.
Foley PW; Muhyaldeen SA; Chalil S; Smith RE; Sanderson JE; Leyva F
Europace; 2009 Apr; 11(4):495-501. PubMed ID: 19307283
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional echocardiographic optimization improves outcome in cardiac resynchronization therapy compared to ECG optimization: a randomized comparison.
Sonne C; Bott-Flugel L; Hauck S; Hadamitzky M; Lesevic H; Demetz G; Braun D; Wolf P; Hausleiter J; Schömig A; Kolb C
Pacing Clin Electrophysiol; 2014 Mar; 37(3):312-20. PubMed ID: 24164640
[TBL] [Abstract][Full Text] [Related]
12. Dyssynchrony, contractile function, and response to cardiac resynchronization therapy.
Knappe D; Pouleur AC; Shah AM; Cheng S; Uno H; Hall WJ; Bourgoun M; Foster E; Zareba W; Goldenberg I; McNitt S; Pfeffer MA; Moss AJ; Solomon SD;
Circ Heart Fail; 2011 Jul; 4(4):433-40. PubMed ID: 21602574
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction).
Linde C; Mealing S; Hawkins N; Eaton J; Brown B; Daubert JC;
Eur Heart J; 2011 Jul; 32(13):1631-9. PubMed ID: 21112898
[TBL] [Abstract][Full Text] [Related]
14. Cardiac resynchronisation therapy in patients with end-stage heart failure--long-term follow-up.
Faran A; Lewicka-Nowak E; Dabrowska-Kugacka A; Kempa M; Tybura S; Szwoch M; Królak T; Raczak G
Kardiol Pol; 2008 Jan; 66(1):19-26; discussion 27. PubMed ID: 18266184
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular lead positioning does not influence the benefits of cardiac resynchronization therapy in patients with heart failure and atrial fibrillation.
Rönn F; Kesek M; Karp K; Henein M; Jensen SM
Europace; 2011 Dec; 13(12):1747-52. PubMed ID: 21712261
[TBL] [Abstract][Full Text] [Related]
16. Cardiac resynchronization therapy in patients with systolic left ventricular dysfunction and symptoms of mild heart failure secondary to ischemic or nonischemic cardiomyopathy.
Bleeker GB; Schalij MJ; Holman ER; Steendijk P; van der Wall EE; Bax JJ
Am J Cardiol; 2006 Jul; 98(2):230-5. PubMed ID: 16828599
[TBL] [Abstract][Full Text] [Related]
17. Effects of cardiac resynchronization therapy in patients unselected for mechanical dyssynchrony.
Foley PW; Chalil S; Khadjooi K; Jordan P; Smith RE; Frenneaux MP; Leyva F
Int J Cardiol; 2010 Aug; 143(1):51-6. PubMed ID: 19246108
[TBL] [Abstract][Full Text] [Related]
18. Clinical and electrocardiographic predictors of a positive response to cardiac resynchronization therapy in advanced heart failure.
Lecoq G; Leclercq C; Leray E; Crocq C; Alonso C; de Place C; Mabo P; Daubert C
Eur Heart J; 2005 Jun; 26(11):1094-100. PubMed ID: 15728648
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the effects of cardiac resynchronization therapy in patients with class II versus class III and IV heart failure (from the InSync/InSync ICD Italian Registry).
Landolina M; Lunati M; Gasparini M; Santini M; Padeletti L; Achilli A; Bianchi S; Laurenzi F; Curnis A; Vincenti A; Valsecchi S; Denaro A;
Am J Cardiol; 2007 Sep; 100(6):1007-12. PubMed ID: 17826388
[TBL] [Abstract][Full Text] [Related]
20. Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure.
Lindenfeld J; Feldman AM; Saxon L; Boehmer J; Carson P; Ghali JK; Anand I; Singh S; Steinberg JS; Jaski B; DeMarco T; Mann D; Yong P; Galle E; Ecklund F; Bristow M
Circulation; 2007 Jan; 115(2):204-12. PubMed ID: 17190867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]